25 XP   0   0   10

Astria Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Astria Therapeutics Inc together

PenkeI guess you are interested in Astria Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Astria Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Astria Therapeutics Inc

I send you an email if I find something interesting about Astria Therapeutics Inc.

Quick analysis of Astria Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Astria Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
8.1%

What is your share worth?

Current worth
$4.43
Expected worth in 1 year
$4.83
How sure are you?
32.4%

+ What do you gain per year?

Total Gains per Share
$0.40
Return On Investment
4.1%

For what price can you sell your share?

Current Price per Share
$9.64
Expected price per share
$8.2 - $16.90
How sure are you?
50%

1. Valuation of Astria Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$9.64

Intrinsic Value Per Share

$-25.32 - $-30.12

Total Value Per Share

$-20.89 - $-25.69

2. Growth of Astria Therapeutics Inc (5 min.)




Is Astria Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$243.1m$135.7m$74m35.3%

How much money is Astria Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$17.6m-$12.3m-$5.2m-29.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Astria Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#214 / 1009

Most Revenue
#868 / 1009

Most Profit
#666 / 1009

Most Efficient
#309 / 1009

What can you expect buying and holding a share of Astria Therapeutics Inc? (5 min.)

Welcome investor! Astria Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Astria Therapeutics Inc.

What can you expect buying and holding a share of Astria Therapeutics Inc?

First you should know what it really means to hold a share of Astria Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Astria Therapeutics Inc is $9.64. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Astria Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Astria Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.43. Based on the TTM, the Book Value Change Per Share is $0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $0.45 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Astria Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.57-5.9%-0.33-3.4%-0.24-2.4%-0.37-3.9%-0.26-2.7%
Usd Book Value Change Per Share1.0711.1%0.101.0%0.454.7%0.192.0%0.121.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.040.5%0.020.2%
Usd Total Gains Per Share1.0711.1%0.101.0%0.454.7%0.232.4%0.141.5%
Usd Price Per Share7.68-9.19-8.41-6.79-5.33-
Price to Earnings Ratio-3.36--8.64--8.86--8.95--7.66-
Price-to-Total Gains Ratio7.19--33.59--0.20--35.69--24.39-
Price to Book Ratio1.73-2.42-3.28-4.25-4.82-
Price-to-Total Gains Ratio7.19--33.59--0.20--35.69--24.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share9.64
Number of shares103
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share0.100.19
Usd Total Gains Per Share0.100.23
Gains per Quarter (103 shares)10.2724.11
Gains per Year (103 shares)41.0996.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104131187886
20827237156182
3012311355234278
4016415473312374
5020519592391470
60247236110469566
70288277128547662
80329318147625758
90370359165703854
100411400183781950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.037.00.00.0%0.037.00.00.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%11.026.00.029.7%11.026.00.029.7%
Dividend per Share0.00.04.00.0%3.00.09.025.0%3.00.017.015.0%3.00.034.08.1%3.00.034.08.1%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%7.013.00.035.0%12.025.00.032.4%12.025.00.032.4%

Fundamentals of Astria Therapeutics Inc

About Astria Therapeutics Inc

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-21 22:39:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Astria Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Astria Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Astria Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-135.3%+135.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y-135.3%-605.5%+470.2%
1.1.2. Return on Assets

Shows how efficient Astria Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • -12.3% Return on Assets means that Astria Therapeutics Inc generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Astria Therapeutics Inc:

  • The MRQ is -12.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.3%TTM-7.9%-4.4%
TTM-7.9%YOY-9.5%+1.6%
TTM-7.9%5Y-16.4%+8.5%
5Y-16.4%10Y-18.7%+2.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.3%-13.3%+1.0%
TTM-7.9%-12.8%+4.9%
YOY-9.5%-11.7%+2.2%
5Y-16.4%-13.9%-2.5%
10Y-18.7%-15.7%-3.0%
1.1.3. Return on Equity

Shows how efficient Astria Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • -12.9% Return on Equity means Astria Therapeutics Inc generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Astria Therapeutics Inc:

  • The MRQ is -12.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.9%TTM-8.3%-4.7%
TTM-8.3%YOY-10.0%+1.8%
TTM-8.3%5Y-11.7%+3.5%
5Y-11.7%10Y-18.7%+7.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.9%-16.9%+4.0%
TTM-8.3%-16.1%+7.8%
YOY-10.0%-15.1%+5.1%
5Y-11.7%-19.3%+7.6%
10Y-18.7%-20.2%+1.5%

1.2. Operating Efficiency of Astria Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Astria Therapeutics Inc is operating .

  • Measures how much profit Astria Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Astria Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-133.3%+133.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y-133.3%-632.4%+499.1%
1.2.2. Operating Ratio

Measures how efficient Astria Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Astria Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y1.396-1.396
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y1.3967.876-6.480

1.3. Liquidity of Astria Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Astria Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 21.73 means the company has $21.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Astria Therapeutics Inc:

  • The MRQ is 21.727. The company is very able to pay all its short-term debts. +2
  • The TTM is 26.350. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ21.727TTM26.350-4.624
TTM26.350YOY112.582-86.232
TTM26.3505Y37.596-11.246
5Y37.59610Y23.265+14.331
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.7273.890+17.837
TTM26.3504.173+22.177
YOY112.5825.344+107.238
5Y37.5966.126+31.470
10Y23.2656.448+16.817
1.3.2. Quick Ratio

Measures if Astria Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 27.51 means the company can pay off $27.51 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Astria Therapeutics Inc:

  • The MRQ is 27.506. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 32.456. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ27.506TTM32.456-4.950
TTM32.456YOY210.368-177.912
TTM32.4565Y60.698-28.242
5Y60.69810Y36.271+24.428
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ27.5063.514+23.992
TTM32.4563.998+28.458
YOY210.3685.380+204.988
5Y60.6986.105+54.593
10Y36.2716.404+29.867

1.4. Solvency of Astria Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Astria Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Astria Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Astria Therapeutics Inc assets are financed with 4.5% credit (debt) and the remaining percentage (100% - 4.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Astria Therapeutics Inc:

  • The MRQ is 0.045. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.039. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.045TTM0.039+0.006
TTM0.039YOY0.049-0.010
TTM0.0395Y0.154-0.115
5Y0.15410Y0.341-0.187
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0450.339-0.294
TTM0.0390.336-0.297
YOY0.0490.271-0.222
5Y0.1540.366-0.212
10Y0.3410.389-0.048
1.4.2. Debt to Equity Ratio

Measures if Astria Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 4.8% means that company has $0.05 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Astria Therapeutics Inc:

  • The MRQ is 0.048. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.041. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.048TTM0.041+0.006
TTM0.041YOY0.052-0.011
TTM0.0415Y0.078-0.037
5Y0.07810Y0.195-0.117
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0480.388-0.340
TTM0.0410.402-0.361
YOY0.0520.335-0.283
5Y0.0780.426-0.348
10Y0.1950.461-0.266

2. Market Valuation of Astria Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Astria Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Astria Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.36 means the investor is paying $-3.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Astria Therapeutics Inc:

  • The EOD is -4.213. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.356. Based on the earnings, the company is expensive. -2
  • The TTM is -8.637. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.213MRQ-3.356-0.856
MRQ-3.356TTM-8.637+5.281
TTM-8.637YOY-8.856+0.219
TTM-8.6375Y-8.952+0.316
5Y-8.95210Y-7.656-1.297
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.213-2.264-1.949
MRQ-3.356-2.629-0.727
TTM-8.637-2.680-5.957
YOY-8.856-4.145-4.711
5Y-8.952-6.257-2.695
10Y-7.656-6.254-1.402
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Astria Therapeutics Inc:

  • The EOD is -4.374. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.484. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.781. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.374MRQ-3.484-0.889
MRQ-3.484TTM-8.781+5.296
TTM-8.781YOY-10.643+1.863
TTM-8.7815Y-10.171+1.390
5Y-10.17110Y-8.697-1.474
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.374-2.973-1.401
MRQ-3.484-3.333-0.151
TTM-8.781-3.553-5.228
YOY-10.643-5.605-5.038
5Y-10.171-8.376-1.795
10Y-8.697-8.865+0.168
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Astria Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.73 means the investor is paying $1.73 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Astria Therapeutics Inc:

  • The EOD is 2.177. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.734. Based on the equity, the company is underpriced. +1
  • The TTM is 2.423. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.177MRQ1.734+0.443
MRQ1.734TTM2.423-0.688
TTM2.423YOY3.277-0.854
TTM2.4235Y4.247-1.825
5Y4.24710Y4.816-0.568
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.1771.896+0.281
MRQ1.7342.115-0.381
TTM2.4232.093+0.330
YOY3.2772.884+0.393
5Y4.2473.542+0.705
10Y4.8163.916+0.900
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Astria Therapeutics Inc.

3.1. Institutions holding Astria Therapeutics Inc

Institutions are holding 88.006% of the shares of Astria Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc8.74820.00284803025223797387.2486
2023-12-31Perceptive Advisors LLC7.2930.68644004070181460882.8792
2023-12-31Fairmount Funds Management LLC6.47352.8843554129165273286.922
2023-12-31Vivo Capital, LLC4.5221.5612248272780152847.676
2023-12-31BlackRock Inc3.97890.0004218455849572229.3529
2023-12-31Vanguard Group Inc3.74420.0003205570754578636.1467
2023-12-31Armistice Capital, LLC2.87420.1654157800015780000
2023-12-31Affinity Asset Advisors, LLC2.6712.057146646546616546.6025
2023-12-31Sphera Funds Management Ltd.2.09671.4229115114557054698.2685
2023-12-31Rosalind Advisors, Inc.2.05587.1392112870811287080
2023-12-31Saturn V Capital Management LLC1.80442.9123990663-228430-18.7377
2023-12-31StemPoint Capital LP1.56081.6448569528569520
2023-12-31Altium Capital Management, LP1.32963.8059730000-617088-45.809
2023-12-31Geode Capital Management, LLC1.26990.000669721519836739.765
2023-12-31Logos Global Management LP0.99260.390754496000
2023-12-31Tri Locum Partners LP0.98891.9061542945-55183-9.226
2023-12-31State Street Corporation0.96490.0002529748356907.2238
2023-12-31Dafna Capital Management LLC0.81780.826344900815351551.9522
2023-12-31Driehaus Capital Management LLC0.77480.0394425364-1028840-70.7494
2023-12-31Morgan Stanley - Brokerage Accounts0.68760.00033775383441881032.048
Total 55.648827.445430552927+10950939+35.8%

3.2. Funds holding Astria Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.66970.0013146574400
2024-03-31SPDR® S&P Biotech ETF2.3880.2431131110369870.5358
2024-03-28iShares Russell 2000 ETF2.20490.02612105665850.0483
2024-01-31Fidelity Series Small Cap Opps1.91960.2654105390500
2024-02-29Fidelity Advisor Biotechnology I1.42610.6261782951-286600-26.7963
2024-01-31Fidelity Small Cap Growth1.26340.1577693648-837-0.1205
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr1.21830.00966886311141719.987
2024-02-29Fidelity Select Biotechnology1.06230.1687583256-223200-27.6766
2024-01-31Fidelity Stock Selector Small Cap0.95150.256952241100
2024-03-28iShares Russell 2000 Growth ETF0.68990.0457378755-440-0.116
2024-01-31Fidelity Advisor Small Cap I0.61950.235534010000
2024-01-31Fidelity Small Cap Index0.61140.017633565629830.8967
2024-02-29Heptagon Driehaus US Micro Cap Eq C$ Acc0.56190.539230847300
2024-03-31State St Russell Sm/Mid Cp® Indx NL Cl C0.47250.00842594006870036.0252
2024-01-31Fidelity Small Cap Growth K60.44350.14852435018370.3449
2024-02-29Fidelity Extended Market Index0.34650.007119025681204.4582
2024-03-31Vanguard Russell 2000 ETF0.33760.02561853756508754.1093
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.32710.02591796005230041.0841
2024-03-31Direxion Daily S&P Biotech Bull 3X ETF0.28510.1764156529-1098-0.6966
2024-03-31BlackRock Health Sciences Term Trust0.23540.091912924000
Total 20.03423.07610999332-195159-1.8%

3.3. Insider Transactions

Insiders are holding 0.488% of the shares of Astria Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-01Perceptive Advisors LlcBUY248135012.09
2024-01-29Christopher MorabitoSELL920011.15
2024-01-26Christopher MorabitoSELL80011.02
2023-12-21Perceptive Advisors LlcBUY7400006.2
2023-10-16Perceptive Advisors LlcBUY10746086.51

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Astria Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.0680.100+971%0.450+137%0.190+463%0.120+792%
Book Value Per Share--4.4283.822+16%2.473+79%1.851+139%1.230+260%
Current Ratio--21.72726.350-18%112.582-81%37.596-42%23.265-7%
Debt To Asset Ratio--0.0450.039+15%0.049-8%0.154-71%0.341-87%
Debt To Equity Ratio--0.0480.041+16%0.052-9%0.078-39%0.195-76%
Dividend Per Share----0%-0%0.045-100%0.024-100%
Eps---0.572-0.332-42%-0.236-59%-0.371-35%-0.264-54%
Free Cash Flow Per Share---0.551-0.312-43%-0.199-64%-0.183-67%-0.158-71%
Free Cash Flow To Equity Per Share--1.0510.091+1059%0.682+54%0.324+225%0.183+474%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---30.123--------
Intrinsic Value_10Y_min---25.315--------
Intrinsic Value_1Y_max---1.177--------
Intrinsic Value_1Y_min---1.155--------
Intrinsic Value_3Y_max---4.940--------
Intrinsic Value_3Y_min---4.688--------
Intrinsic Value_5Y_max---10.395--------
Intrinsic Value_5Y_min---9.528--------
Market Cap529265884.000+20%421655808.000504696746.750-16%461735071.000-9%372929306.750+13%292543007.078+44%
Net Profit Margin----0%-0%-0%-1.3530%
Operating Margin----0%-0%-0%-1.3330%
Operating Ratio----0%-0%-0%1.396-100%
Pb Ratio2.177+20%1.7342.423-28%3.277-47%4.247-59%4.816-64%
Pe Ratio-4.213-26%-3.356-8.637+157%-8.856+164%-8.952+167%-7.656+128%
Price Per Share9.640+20%7.6809.193-16%8.410-9%6.793+13%5.328+44%
Price To Free Cash Flow Ratio-4.374-26%-3.484-8.781+152%-10.643+205%-10.171+192%-8.697+150%
Price To Total Gains Ratio9.026+20%7.191-33.589+567%-0.196+103%-35.692+596%-24.393+439%
Quick Ratio--27.50632.456-15%210.368-87%60.698-55%36.271-24%
Return On Assets---0.123-0.079-36%-0.095-23%-0.164+33%-0.187+52%
Return On Equity---0.129-0.083-36%-0.100-22%-0.117-9%-0.187+45%
Total Gains Per Share--1.0680.100+971%0.450+137%0.234+356%0.144+643%
Usd Book Value--243116000.000209839250.000+16%135798250.000+79%101640900.000+139%67527567.568+260%
Usd Book Value Change Per Share--1.0680.100+971%0.450+137%0.190+463%0.120+792%
Usd Book Value Per Share--4.4283.822+16%2.473+79%1.851+139%1.230+260%
Usd Dividend Per Share----0%-0%0.045-100%0.024-100%
Usd Eps---0.572-0.332-42%-0.236-59%-0.371-35%-0.264-54%
Usd Free Cash Flow---30254000.000-17117500.000-43%-10906000.000-64%-10066050.000-67%-8679027.027-71%
Usd Free Cash Flow Per Share---0.551-0.312-43%-0.199-64%-0.183-67%-0.158-71%
Usd Free Cash Flow To Equity Per Share--1.0510.091+1059%0.682+54%0.324+225%0.183+474%
Usd Market Cap529265884.000+20%421655808.000504696746.750-16%461735071.000-9%372929306.750+13%292543007.078+44%
Usd Price Per Share9.640+20%7.6809.193-16%8.410-9%6.793+13%5.328+44%
Usd Profit---31410000.000-17646500.000-44%-12364000.000-61%-18927350.000-40%-13689108.108-56%
Usd Revenue----0%-0%-0%13513.514-100%
Usd Total Gains Per Share--1.0680.100+971%0.450+137%0.234+356%0.144+643%
 EOD+6 -2MRQTTM+12 -17YOY+14 -155Y+17 -1410Y+19 -14

4.2. Fundamental Score

Let's check the fundamental score of Astria Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.213
Price to Book Ratio (EOD)Between0-12.177
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than127.506
Current Ratio (MRQ)Greater than121.727
Debt to Asset Ratio (MRQ)Less than10.045
Debt to Equity Ratio (MRQ)Less than10.048
Return on Equity (MRQ)Greater than0.15-0.129
Return on Assets (MRQ)Greater than0.05-0.123
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Astria Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.358
Ma 20Greater thanMa 5011.541
Ma 50Greater thanMa 10013.333
Ma 100Greater thanMa 20010.806
OpenGreater thanClose9.650
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets254,666
Total Liabilities11,550
Total Stockholder Equity243,116
 As reported
Total Liabilities 11,550
Total Stockholder Equity+ 243,116
Total Assets = 254,666

Assets

Total Assets254,666
Total Current Assets250,942
Long-term Assets3,724
Total Current Assets
Cash And Cash Equivalents 175,693
Short-term Investments 71,000
Other Current Assets 4,249
Total Current Assets  (as reported)250,942
Total Current Assets  (calculated)250,942
+/-0
Long-term Assets
Property Plant Equipment 363
Long-term Assets Other 3,361
Long-term Assets  (as reported)3,724
Long-term Assets  (calculated)3,724
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,550
Long-term Liabilities0
Total Stockholder Equity243,116
Total Current Liabilities
Short-term Debt 329
Accounts payable 1,513
Other Current Liabilities 9,708
Total Current Liabilities  (as reported)11,550
Total Current Liabilities  (calculated)11,550
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock41
Retained Earnings -580,534
Other Stockholders Equity 728,326
Total Stockholder Equity (as reported)243,116
Total Stockholder Equity (calculated)147,833
+/- 95,283
Other
Capital Stock95,365
Cash and Short Term Investments 246,693
Common Stock Shares Outstanding 36,523
Liabilities and Stockholders Equity 254,666
Net Debt -175,364
Net Invested Capital 147,792
Net Working Capital 239,392
Property Plant and Equipment Gross 363
Short Long Term Debt Total 329



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
0
0
0
15,964
26,725
82,454
73,657
64,223
54,269
44,560
48,940
40,209
33,422
30,816
23,313
17,897
18,290
50,847
44,699
39,169
54,497
48,529
43,834
41,780
59,176
57,087
56,850
47,456
148,740
140,945
135,129
127,514
114,653
105,293
119,817
230,633
218,240
207,053
193,861
254,666
254,666193,861207,053218,240230,633119,817105,293114,653127,514135,129140,945148,74047,45656,85057,08759,17641,78043,83448,52954,49739,16944,69950,84718,29017,89723,31330,81633,42240,20948,94044,56054,26964,22373,65782,45426,72515,964000
   > Total Current Assets 
0
0
0
15,022
24,854
82,076
73,300
63,584
53,386
43,729
48,299
39,528
32,815
30,261
22,812
17,463
17,919
50,683
44,541
38,915
52,649
46,991
42,726
38,958
57,140
55,598
55,512
46,325
147,684
140,052
134,522
127,075
114,221
103,821
118,485
226,437
215,445
204,414
191,466
250,942
250,942191,466204,414215,445226,437118,485103,821114,221127,075134,522140,052147,68446,32555,51255,59857,14038,95842,72646,99152,64938,91544,54150,68317,91917,46322,81230,26132,81539,52848,29943,72953,38663,58473,30082,07624,85415,022000
       Cash And Cash Equivalents 
0
0
0
14,668
24,303
81,548
72,709
62,780
23,818
24,278
26,464
23,596
31,795
29,369
21,713
16,369
17,030
49,931
19,876
15,294
11,652
9,615
17,765
9,899
13,344
51,885
52,856
24,930
146,920
139,520
131,777
86,508
46,687
29,826
45,972
20,525
202,301
133,958
119,806
175,693
175,693119,806133,958202,30120,52545,97229,82646,68786,508131,777139,520146,92024,93052,85651,88513,3449,89917,7659,61511,65215,29419,87649,93117,03016,36921,71329,36931,79523,59626,46424,27823,81862,78072,70981,54824,30314,668000
       Short-term Investments 
0
0
0
0
0
0
0
0
28,758
18,539
20,803
14,931
0
0
0
0
0
0
23,363
22,276
40,012
36,496
22,850
26,345
41,759
2,001
0
20,000
20,000
0
0
39,000
66,129
72,652
70,599
205,912
11,027
69,000
69,000
71,000
71,00069,00069,00011,027205,91270,59972,65266,12939,0000020,00020,00002,00141,75926,34522,85036,49640,01222,27623,36300000014,93120,80318,53928,75800000000
       Other Current Assets 
0
0
0
354
551
528
591
804
810
912
1,032
1,001
1,020
892
1,099
1,094
889
752
1,302
1,345
985
880
2,111
2,714
2,037
1,712
2,656
1,395
764
532
2,745
40,567
1,405
1,343
1,914
1,253
2,117
1,456
2,660
4,249
4,2492,6601,4562,1171,2531,9141,3431,40540,5672,7455327641,3952,6561,7122,0372,7142,1118809851,3451,3027528891,0941,0998921,0201,0011,032912810804591528551354000
   > Long-term Assets 
0
0
0
942
1,871
378
357
639
883
831
641
681
607
555
501
434
371
164
158
254
1,848
1,538
1,108
2,822
2,036
1,489
1,338
1,131
1,056
893
607
439
432
1,472
1,332
4,196
2,795
2,639
2,395
3,724
3,7242,3952,6392,7954,1961,3321,4724324396078931,0561,1311,3381,4892,0362,8221,1081,5381,8482541581643714345015556076816418318836393573781,871942000
       Property Plant Equipment 
0
0
0
288
260
230
216
504
770
718
641
568
494
442
388
321
258
51
45
56
1,625
1,274
965
2,349
1,799
1,326
1,178
966
874
717
557
394
228
1,282
1,087
948
806
661
514
363
3635146618069481,0871,2822283945577178749661,1781,3261,7992,3499651,2741,625564551258321388442494568641718770504216230260288000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160
165
182
176
135,129
45
204
0
245
3,248
0
1,978
0
0
001,97803,248245020445135,12917618216516000000000000000000000000000
> Total Liabilities 
0
0
0
89,017
13,238
14,866
14,113
13,730
12,545
11,746
12,079
11,123
9,467
9,266
7,656
6,105
5,359
5,035
4,180
4,227
4,628
5,168
5,561
6,060
5,465
6,227
7,539
6,787
249,885
4,046
4,700
5,203
4,967
5,874
6,945
9,417
6,880
6,651
9,382
11,550
11,5509,3826,6516,8809,4176,9455,8744,9675,2034,7004,046249,8856,7877,5396,2275,4656,0605,5615,1684,6284,2274,1805,0355,3596,1057,6569,2669,46711,12312,07911,74612,54513,73014,11314,86613,23889,017000
   > Total Current Liabilities 
0
0
0
4,234
4,993
7,395
7,411
7,811
7,431
7,422
8,541
8,325
7,496
8,129
7,559
6,016
5,277
4,961
4,125
4,171
4,298
5,168
5,561
5,032
4,590
5,509
6,980
6,390
4,406
3,988
4,700
5,203
4,967
5,225
6,441
582
6,673
6,598
9,382
11,550
11,5509,3826,5986,6735826,4415,2254,9675,2034,7003,9884,4066,3906,9805,5094,5905,0325,5615,1684,2984,1714,1254,9615,2776,0167,5598,1297,4968,3258,5417,4227,4317,8117,4117,3954,9934,234000
       Short-term Debt 
0
0
0
309
1,505
2,346
3,191
3,205
3,190
3,207
3,225
3,243
3,260
3,278
3,296
2,479
1,657
831
0
0
1,259
1,266
929
1,225
879
645
648
649
652
655
541
365
184
573
578
582
587
590
488
329
3294885905875825785731843655416556526496486458791,2259291,2661,259008311,6572,4793,2963,2783,2603,2433,2253,2073,1903,2053,1912,3461,505309000
       Accounts payable 
0
0
0
1,132
2,021
2,486
1,783
1,328
1,626
1,559
1,721
1,405
942
2,055
1,202
773
1,115
785
1,047
1,408
1,588
1,390
2,156
1,197
709
1,169
1,408
1,544
1,809
619
574
1,557
931
995
790
788
930
829
1,138
1,513
1,5131,1388299307887909959311,5575746191,8091,5441,4081,1697091,1972,1561,3901,5881,4081,0477851,1157731,2022,0559421,4051,7211,5591,6261,3281,7832,4862,0211,132000
       Other Current Liabilities 
0
0
0
2,793
1,467
2,563
2,437
3,278
2,615
2,656
3,595
3,677
3,294
2,796
321
332
341
346
3,078
2,763
1,451
2,492
2,446
2,570
2,952
3,652
4,924
4,197
1,945
2,714
3,585
3,281
3,852
3,657
5,073
-788
5,156
5,179
7,756
9,708
9,7087,7565,1795,156-7885,0733,6573,8523,2813,5852,7141,9454,1974,9243,6522,9522,5702,4462,4921,4512,7633,0783463413323212,7963,2943,6773,5952,6562,6153,2782,4372,5631,4672,793000
   > Long-term Liabilities 
0
0
0
84,783
8,245
7,471
6,702
5,919
5,114
4,324
3,538
2,798
1,971
1,137
97
89
82
74
55
56
330
0
0
1,028
875
718
559
397
245,479
58
4,159
1,922
1,115
649
504
8,835
207
53
0
0
00532078,8355046491,1151,9224,15958245,4793975597188751,028003305655748289971,1371,9712,7983,5384,3245,1145,9196,7027,4718,24584,783000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,369
0
0
0
0
0
0
0
0
0
0
0
000000000004,3690000000000000000000000000000
> Total Stockholder Equity
0
0
0
-73,053
13,487
67,588
59,544
50,493
41,724
32,814
36,861
29,086
23,955
21,550
15,657
11,792
12,931
45,812
40,519
34,942
49,869
43,361
38,273
35,720
53,711
50,860
49,311
40,669
-101,145
136,899
130,429
122,311
109,686
99,419
112,872
221,216
211,360
200,402
184,479
243,116
243,116184,479200,402211,360221,216112,87299,419109,686122,311130,429136,899-101,14540,66949,31150,86053,71135,72038,27343,36149,86934,94240,51945,81212,93111,79215,65721,55023,95529,08636,86132,81441,72450,49359,54467,58813,487-73,053000
   Common Stock
0
0
0
1
10
15
15
15
15
15
19
19
20
22
23
24
29
71
71
7
11
12
12
12
18
19
20
20
23
77
13
13
13
13
16
28
28
28
28
41
412828282816131313137723202019181212121177171292423222019191515151515101000
   Retained Earnings Total Equity00-531,397-518,831-507,643-494,380-482,383000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-82,454
-73,657
-64,223
14
8
-3
-4
0
0
0
0
0
0
-5
-4
0
1
0
0
-15
1
0
0
-240,881
0
0
-96,398
-53
-186
-215
-79
-4
-95,324
-95,324
-41
-41-95,324-95,324-4-79-215-186-53-96,39800-240,881001-150010-4-5000000-4-3814-64,223-73,657-82,45400000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
485,577
511,053
632,512
634,843
636,447
0
0
00636,447634,843632,512511,053485,577000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
2,326
95,357
157,493
157,933
158,488
159,123
159,664
172,137
173,141
175,881
180,448
181,571
183,202
191,988
231,306
231,697
232,243
253,200
253,821
255,248
259,305
285,257
291,897
301,210
301,546
329,813
475,499
480,336
578,107
484,460
485,577
511,053
632,512
634,843
731,771
733,575
728,326
728,326733,575731,771634,843632,512511,053485,577484,460578,107480,336475,499329,813301,546301,210291,897285,257259,305255,248253,821253,200232,243231,697231,306191,988183,202181,571180,448175,881173,141172,137159,664159,123158,488157,933157,49395,3572,326000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-67,831
Operating Income-67,831-67,831
 
Operating Expense (+$)
Research Development42,127
Selling General Administrative25,704
Selling And Marketing Expenses0
Operating Expense67,83167,831
 
Net Interest Income (+$)
Interest Income10,201
Interest Expense-0
Other Finance Cost-0
Net Interest Income10,201
 
Pretax Income (+$)
Operating Income-67,831
Net Interest Income10,201
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-72,891-62,771
EBIT - interestExpense = 0
-72,891
-72,891
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-72,891
Earnings Before Interest and Taxes (EBITDA)-67,831
 
After tax Income (+$)
Income Before Tax-72,891
Tax Provision-0
Net Income From Continuing Ops-72,891-72,891
Net Income-72,891
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,831
Total Other Income/Expenses Net-5,060-10,201
 

Technical Analysis of Astria Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Astria Therapeutics Inc. The general trend of Astria Therapeutics Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Astria Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Astria Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.25 < 12.51 < 16.90.

The bearish price targets are: 9.3 > 8.44 > 8.2.

Tweet this
Astria Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Astria Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Astria Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Astria Therapeutics Inc. The current macd is -1.03923045.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Astria Therapeutics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Astria Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Astria Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Astria Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAstria Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Astria Therapeutics Inc. The current adx is 26.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Astria Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Astria Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Astria Therapeutics Inc. The current sar is 10.80.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Astria Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Astria Therapeutics Inc. The current rsi is 27.36. The current phase is Oversold in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bull market: Short-term excessive selling, potential for rebound. Consider buying at a perceived discount, watch for reversal signs. +1
  • Trending down: The RSI is trending down. -1
Astria Therapeutics Inc Daily Relative Strength Index (RSI) ChartAstria Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Astria Therapeutics Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Astria Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Astria Therapeutics Inc Daily Stochastic Oscillator ChartAstria Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Astria Therapeutics Inc. The current cci is -117.23187946.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Astria Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAstria Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Astria Therapeutics Inc. The current cmo is -59.71500852.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Astria Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAstria Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Astria Therapeutics Inc. The current willr is -94.92847854.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Astria Therapeutics Inc Daily Williams %R ChartAstria Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Astria Therapeutics Inc.

Astria Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Astria Therapeutics Inc. The current atr is 0.86186613.

Astria Therapeutics Inc Daily Average True Range (ATR) ChartAstria Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Astria Therapeutics Inc. The current obv is 24,556,926.

Astria Therapeutics Inc Daily On-Balance Volume (OBV) ChartAstria Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Astria Therapeutics Inc. The current mfi is 27.06.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Astria Therapeutics Inc Daily Money Flow Index (MFI) ChartAstria Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Astria Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Astria Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Astria Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.358
Ma 20Greater thanMa 5011.541
Ma 50Greater thanMa 10013.333
Ma 100Greater thanMa 20010.806
OpenGreater thanClose9.650
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Astria Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Astria Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Astria Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Astria Therapeutics Inc

I send you an email if I find something interesting about Astria Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Astria Therapeutics Inc.

Receive notifications about Astria Therapeutics Inc in your mailbox!